1 active not recruiting, 1 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
Follow End-Stage Liver Diseases: new trials by email Literature Review of End-Stage Liver Diseases trials Research Report on End-Stage Liver Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD Infusion of umbilical cord-mesenchymal stem cells through peripheral veins, Infusion of umbilical cord-mesenchymal stem cells through hepatic artery - End-Stage Liver Diseases | Not applicable | Active not recruiting | General Hospital of Shenyang Military Region | 32 | 2026-02-01 | 2026-09-15 |
| Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD umbilical cord-mesenchymal stem cells - End-stage Liver Diseases | Not applicable | Completed | General Hospital of Shenyang Military Region | 22 | 2023-11-28 | 2026-04-03 |
Fibrosis (2)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
General Hospital of Shenyang Military Region (2)
China (2)
Liyan Dong, MM (1) · Mengfan Ruan, MM (1) · Xingshun Qi, MD (1)
PMID 19654548, PMID 29425678, PMID 32977828, PMID 33764490, PMID 34597754